Literature DB >> 6227362

Acne vulgaris and hidradenitis suppurativa as presenting features of acromegaly.

R J Chalmers, R D Ead, M H Beck, P Dewis, D C Anderson.   

Abstract

Entities:  

Mesh：

Year:  1983        PMID： 6227362      PMCID： PMC1549472          DOI： 10.1136/bmj.287.6402.1346-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  4 in total

1.  Sebum excretion in acromegaly.

Authors:  J L Burton; L J Libman; W J Cunliffe; R Wilkinson; R Hall; S Shuster
Journal:  Br Med J       Date:  1972-02-12

2.  Skin changes in acromegaly.

Authors:  H Materlik; T Slówko; A Jedrzejczak
Journal:  Pol Med J       Date:  1968

3.  Severity of acne and sebum excretion rate.

Authors:  J A Cotterill; W J Cunliffe; B Williamson
Journal:  Br J Dermatol       Date:  1971-07       Impact factor: 9.302

4.  The acromegaly syndrome. Relation between clinical features, growth hormone values and radiological characteristics of the pituitary tumours.

Authors:  A Jadresic; L M Banks; D F Child; L Diamant; F H Doyle; T R Fraser; G F Joplin
Journal:  Q J Med       Date:  1982
  4 in total
  5 in total

1.  Comorbidities of hidradenitis suppurativa (acne inversa).

Authors:  Sabine Fimmel; Christos C Zouboulis
Journal:  Dermatoendocrinol       Date:  2010-01

Review 2.  The skin in diabetes mellitus.

Authors:  M J Goodfield; L G Millard
Journal:  Diabetologia       Date:  1988-08       Impact factor: 10.122

Review 3.  Skin manifestations of growth hormone-induced diseases.

Authors:  Christina Kanaka-Gantenbein; Christina Kogia; Mohamed Badawy Abdel-Naser; George P Chrousos
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

4.  Mediation of hidradenitis suppurativa by androgens.

Authors:  P S Mortimer; R P Dawber; M A Gales; R A Moore
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-25

Review 5.  Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder?

Authors:  Ioannis Karagiannidis; Georgios Nikolakis; Robert Sabat; Christos C Zouboulis
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.